Terms: = Prostate cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
16 results:
1. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
[TBL] [Abstract] [Full Text] [Related]
2. Lymphatic Dissemination in prostate cancer: Features of the Transcriptomic Profile and Prognostic Models.
Pudova EA; Kobelyatskaya AA; Katunina IV; Snezhkina AV; Fedorova MS; Pavlov VS; Bakhtogarimov IR; Lantsova MS; Kokin SP; Nyushko KM; Alekseev BY; Kalinin DV; Melnikova NV; Dmitriev AA; Krasnov GS; Kudryavtseva AV
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768739
[TBL] [Abstract] [Full Text] [Related]
3. Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy.
Wrenger R; Jüptner M; Marx M; Zhao Y; Zuhayra M; Caliebe A; Osmonov D; Lützen U
BMC Urol; 2022 Jul; 22(1):96. PubMed ID: 35788220
[TBL] [Abstract] [Full Text] [Related]
4. MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
He D; Wang X; Fu C; Wei X; Bao J; Ji X; Bai H; Xia W; Gao X; Huang Y; Hou J
Cancer Imaging; 2021 Jul; 21(1):46. PubMed ID: 34225808
[TBL] [Abstract] [Full Text] [Related]
5. prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant prostate cancer: Any Rise in prostate-specific Antigen May Require Closer Monitoring.
Saad F; Sternberg CN; Efstathiou E; Fizazi K; Modelska K; Lin X; Sugg J; Steinberg J; Noerby B; Shore ND; Hussain M
Eur Urol; 2020 Dec; 78(6):847-853. PubMed ID: 33010985
[TBL] [Abstract] [Full Text] [Related]
6. Retzius Sparing Robot-Assisted Radical prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients.
Lee J; Kim HY; Goh HJ; Heo JE; Almujalhem A; Alqahtani AA; Chung DY; Chang K; Choi YD; Rha KH
J Urol; 2020 Jan; 203(1):137-144. PubMed ID: 31347951
[TBL] [Abstract] [Full Text] [Related]
7. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract] [Full Text] [Related]
8. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
Schmidt B; Eapen RS; Cowan JE; Broering JM; Greene KL; Carroll PR; Cooperberg MR
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):117-124. PubMed ID: 30171230
[TBL] [Abstract] [Full Text] [Related]
9. Incorporating Biomarkers into the Primary prostate Biopsy Setting: A Cost-Effectiveness Analysis.
Sathianathen NJ; Kuntz KM; Alarid-Escudero F; Lawrentschuk NL; Bolton DM; Murphy DG; Weight CJ; Konety BR
J Urol; 2018 Dec; 200(6):1215-1220. PubMed ID: 29906434
[TBL] [Abstract] [Full Text] [Related]
10. Estimation of Future cancer Burden Among Rescue and Recovery Workers Exposed to the World Trade Center Disaster.
Singh A; Zeig-Owens R; Moir W; Hall CB; Schwartz T; Vossbrinck M; Jaber N; Webber MP; Kelly KJ; Ortiz V; Koffler E; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):828-831. PubMed ID: 29710126
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy.
Mulders PF; Molina A; Marberger M; Saad F; Higano CS; Chi KN; Li J; Kheoh T; Haqq CM; Fizazi K
Eur Urol; 2014 May; 65(5):875-83. PubMed ID: 24099659
[TBL] [Abstract] [Full Text] [Related]
12. PRIMO: a graphical environment for the Monte Carlo simulation of Varian and Elekta linacs.
Rodriguez M; Sempau J; Brualla L
Strahlenther Onkol; 2013 Oct; 189(10):881-6. PubMed ID: 24005581
[TBL] [Abstract] [Full Text] [Related]
13. Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy.
Pettersson N; Olsson C; Tucker SL; Alsadius D; Wilderäng U; Johansson KA; Steineck G
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e29-37. PubMed ID: 23237005
[TBL] [Abstract] [Full Text] [Related]
14. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types.
Zucca AC; Boyes AW; Linden W; Girgis A
J Pain Symptom Manage; 2012 Apr; 43(4):720-31. PubMed ID: 22277904
[TBL] [Abstract] [Full Text] [Related]
15. prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience.
Kim CK; Park BK; Park W; Kim SS
Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116
[TBL] [Abstract] [Full Text] [Related]
16. A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer.
Samant RS; Dunscombe PB; Roberts GH
Urol Oncol; 2003; 21(3):171-7. PubMed ID: 12810202
[TBL] [Abstract] [Full Text] [Related]
